什么是治疗诊断学？ - Suppr

Suppr

超能文献

What Is Theranostics?

作者信息

Weber Wolfgang A, Barthel Henryk, Bengel Frank, Eiber Matthias, Herrmann Ken, Schäfers Michael

机构信息

Technical University of Munich, Munich, Germany.

Leipzig University, Leipzig, German.

出版信息

J Nucl Med. 2023 May;64(5):669-670. doi: 10.2967/jnumed.123.265670. Epub 2023 Apr 13.

DOI:10.2967/jnumed.123.265670

PMID:37055220

Abstract

摘要

相似文献

What Is Theranostics?

J Nucl Med. 2023 May;64(5):669-670. doi: 10.2967/jnumed.123.265670. Epub 2023 Apr 13.

Theranostics and precision medicine special feature.

Br J Radiol. 2018 Nov;91(1091):20189004. doi: 10.1259/bjr.20189004.

Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1595. doi: 10.1002/wnan.1595. Epub 2019 Oct 23.

Ultrasound-based nanomedicine for molecular imaging of prostate cancer: from diagnostics to theranostics.

Nanomedicine (Lond). 2021 Oct;16(23):2029-2032. doi: 10.2217/nnm-2021-0170. Epub 2021 Sep 14.

Reply to "Theranostics Is Not Radiotheranostics".

J Nucl Med. 2023 Dec 1;64(12):2002. doi: 10.2967/jnumed.123.266491.

Theranostics Is Not Radiotheranostics.

J Nucl Med. 2023 Dec 1;64(12):2002. doi: 10.2967/jnumed.123.266292.

Not All Gatekeepers Are Theranostics.

J Nucl Med. 2023 Oct;64(10):1662. doi: 10.2967/jnumed.123.266006. Epub 2023 Jun 29.

Reply to: Not All Gatekeepers Are Theranostics.

J Nucl Med. 2023 Oct;64(10):1662-1663. doi: 10.2967/jnumed.123.266028. Epub 2023 Jun 29.

The ICPO Foundation-on the way toward collaborative growth of theranostics.

Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):443-444. doi: 10.1007/s00259-021-05651-2.

Nanoparticle theranostics in cardiovascular inflammation.

Semin Immunol. 2021 Aug;56:101536. doi: 10.1016/j.smim.2021.101536. Epub 2021 Nov 30.

引用本文的文献

From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration.

Front Neurol. 2025 Aug 5;16:1637243. doi: 10.3389/fneur.2025.1637243. eCollection 2025.

Ga Extemporaneous Preparations in Radiopharmacy.

Pharmaceutics. 2025 Jun 20;17(7):802. doi: 10.3390/pharmaceutics17070802.

Recent advances in theranostics and oncology PET: emerging radionuclides and targets.

Ann Nucl Med. 2025 Sep;39(9):909-921. doi: 10.1007/s12149-025-02090-z. Epub 2025 Jul 27.

Novel molecular imaging approaches in oncology: towards a more accurate estimation of tumour response.

Curr Opin Oncol. 2025 Sep 1;37(5):522-528. doi: 10.1097/CCO.0000000000001166. Epub 2025 Jul 9.

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells.

Theranostics. 2025 May 25;15(13):6497-6515. doi: 10.7150/thno.113354. eCollection 2025.

An Update on DOTA-Peptides PET Imaging and Potential Advancements of Radioligand Therapy in Intracranial Meningiomas.

Life (Basel). 2025 Apr 7;15(4):617. doi: 10.3390/life15040617.

Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy.

Cancers (Basel). 2025 Apr 7;17(7):1247. doi: 10.3390/cancers17071247.

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6.

Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology.

Chem Biomed Imaging. 2023 Nov 15;2(3):168-184. doi: 10.1021/cbmi.3c00093. eCollection 2024 Mar 25.

Assembling a new generation of radiopharmaceuticals with supramolecular theranostics.

Nat Rev Chem. 2024 Dec;8(12):893-914. doi: 10.1038/s41570-024-00657-4. Epub 2024 Oct 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

What Is Theranostics?

J Nucl Med. 2023 May;64(5):669-670. doi: 10.2967/jnumed.123.265670. Epub 2023 Apr 13.

Theranostics and precision medicine special feature.

Br J Radiol. 2018 Nov;91(1091):20189004. doi: 10.1259/bjr.20189004.

Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1595. doi: 10.1002/wnan.1595. Epub 2019 Oct 23.

Ultrasound-based nanomedicine for molecular imaging of prostate cancer: from diagnostics to theranostics.

Nanomedicine (Lond). 2021 Oct;16(23):2029-2032. doi: 10.2217/nnm-2021-0170. Epub 2021 Sep 14.

Reply to "Theranostics Is Not Radiotheranostics".

J Nucl Med. 2023 Dec 1;64(12):2002. doi: 10.2967/jnumed.123.266491.

Theranostics Is Not Radiotheranostics.

J Nucl Med. 2023 Dec 1;64(12):2002. doi: 10.2967/jnumed.123.266292.

Not All Gatekeepers Are Theranostics.

J Nucl Med. 2023 Oct;64(10):1662. doi: 10.2967/jnumed.123.266006. Epub 2023 Jun 29.

Reply to: Not All Gatekeepers Are Theranostics.

J Nucl Med. 2023 Oct;64(10):1662-1663. doi: 10.2967/jnumed.123.266028. Epub 2023 Jun 29.

The ICPO Foundation-on the way toward collaborative growth of theranostics.

Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):443-444. doi: 10.1007/s00259-021-05651-2.

Nanoparticle theranostics in cardiovascular inflammation.

Semin Immunol. 2021 Aug;56:101536. doi: 10.1016/j.smim.2021.101536. Epub 2021 Nov 30.

引用本文的文献

From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration.

Front Neurol. 2025 Aug 5;16:1637243. doi: 10.3389/fneur.2025.1637243. eCollection 2025.

Ga Extemporaneous Preparations in Radiopharmacy.

Pharmaceutics. 2025 Jun 20;17(7):802. doi: 10.3390/pharmaceutics17070802.

Recent advances in theranostics and oncology PET: emerging radionuclides and targets.

Ann Nucl Med. 2025 Sep;39(9):909-921. doi: 10.1007/s12149-025-02090-z. Epub 2025 Jul 27.

Novel molecular imaging approaches in oncology: towards a more accurate estimation of tumour response.

Curr Opin Oncol. 2025 Sep 1;37(5):522-528. doi: 10.1097/CCO.0000000000001166. Epub 2025 Jul 9.

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells.

Theranostics. 2025 May 25;15(13):6497-6515. doi: 10.7150/thno.113354. eCollection 2025.

An Update on DOTA-Peptides PET Imaging and Potential Advancements of Radioligand Therapy in Intracranial Meningiomas.

Life (Basel). 2025 Apr 7;15(4):617. doi: 10.3390/life15040617.

Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy.

Cancers (Basel). 2025 Apr 7;17(7):1247. doi: 10.3390/cancers17071247.

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6.

Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology.

Chem Biomed Imaging. 2023 Nov 15;2(3):168-184. doi: 10.1021/cbmi.3c00093. eCollection 2024 Mar 25.

Assembling a new generation of radiopharmaceuticals with supramolecular theranostics.

Nat Rev Chem. 2024 Dec;8(12):893-914. doi: 10.1038/s41570-024-00657-4. Epub 2024 Oct 28.